Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × Population Groups × Clear all

Phase

Phase NA 20 Phase 1 4 Phase 2 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 241 Radiotherapy 200 Fluorouracil 171 Cyclophosphamide 165 Capecitabine 162 Docetaxel 146 Oxaliplatin 138 Gemcitabine 133 Carboplatin 130 Paclitaxel 128 Dexamethasone 109 Leucovorin 101 Drug Therapy 101 Doxorubicin 99 Etoposide 83 Cytarabine 75 Bevacizumab 74 Vincristine 71 Irinotecan 65 Rituximab 64 Epirubicin 63 Methotrexate 54 Prednisone 53 Radiosurgery 52 Surgical Procedures, Operative 50 Radiotherapy, Intensity-Modulated 49 Radiation 49 Lenalidomide 48 Neoadjuvant Therapy 47 Chemotherapy, Adjuvant 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01536223 2013-03-05

ESNCCT

Zhejiang Cancer Hospital

Phase 3 Unknown

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡